Back to top
more

Canopy Growth (CGC)

(Delayed Data from NSDQ)

$1.36 USD

1.36
17,249,563

-0.09 (-6.21%)

Updated Sep 17, 2025 04:00 PM ET

Pre-Market: $1.38 +0.02 (1.47%) 9:24 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.64%
2Buy17.83%
3Hold9.69%
4Sell5.29%
5Strong Sell2.54%
S&P50011.29%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

F Value C Growth F Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 40% (98 out of 245)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Sundeep Ganoria headshot

Cannabis Operator Curaleaf Plunges 46% YTD: Time to Sell or Hold?

by Sundeep Ganoria

CURLF dives 46% YTD as domestic headwinds outweigh global growth; is it time to cash out or wait for a rebound?

Zacks Equity Research

Canopy Growth Corporation (CGC) Stock Declines While Market Improves: Some Information for Investors

by Zacks Equity Research

In the closing of the recent trading day, Canopy Growth Corporation (CGC) stood at $1.19, denoting a -4.03% move from the preceding trading day.

Zacks Equity Research

Canopy Growth Corporation (CGC) is Attracting Investor Attention: Here is What You Should Know

by Zacks Equity Research

Canopy Growth (CGC) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Sundeep Ganoria headshot

Could the New Federal Bill Derail the U.S. Hemp Industry?

by Sundeep Ganoria

A proposed federal bill could upend the U.S. hemp market, threatening CBD and Delta-8 products now sold nationwide.

Zacks Equity Research

Canopy Growth Corporation (CGC) Stock Drops Despite Market Gains: Important Facts to Note

by Zacks Equity Research

In the closing of the recent trading day, Canopy Growth Corporation (CGC) stood at $1.45, denoting a -2.03% move from the preceding trading day.

Sundeep Ganoria headshot

Cannabis Stock CGC Rallies 39% in Three Months: Time to Buy or Sell?

by Sundeep Ganoria

Canopy Growth surges 39% in three months as restructuring, margin gains and debt cuts renew investor interest.

Sundeep Ganoria headshot

Cannabis Operator VFF Sells Fresh Produce Unit: How to Play the Stock?

by Sundeep Ganoria

After dropping its produce business, Village Farms sharpens its cannabis focus - boosting exports, margins and market share.

Zacks Equity Research

Canopy Growth Corporation (CGC) Is a Trending Stock: Facts to Know Before Betting on It

by Zacks Equity Research

Canopy Growth (CGC) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Sundeep Ganoria headshot

Aurora Cannabis Stock Rises 30% YTD: Time to Buy or Sell?

by Sundeep Ganoria

ACB's 30% YTD rally reflects Q3 strength, but flat EPS estimates and consumer weakness keep analysts cautious about long-term upside.

Zacks Equity Research

Canopy Growth Corporation (CGC) Reports Q4 Loss, Lags Revenue Estimates

by Zacks Equity Research

Canopy Growth (CGC) delivered earnings and revenue surprises of -840% and 9.41%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Canopy Growth Corporation (CGC) is Attracting Investor Attention: Here is What You Should Know

by Zacks Equity Research

Zacks.com users have recently been watching Canopy Growth (CGC) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Zacks Equity Research

Canopy Growth Corporation (CGC) Stock Falls Amid Market Uptick: What Investors Need to Know

by Zacks Equity Research

Canopy Growth Corporation (CGC) concluded the recent trading session at $1.64, signifying a -1.51% move from its prior day's close.

Zacks Equity Research

TriSalus Life Sciences, Inc. (TLSI) Reports Q1 Loss, Lags Revenue Estimates

by Zacks Equity Research

TriSalus Life Sciences, Inc. (TLSI) delivered earnings and revenue surprises of -65% and 1.04%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Canopy Growth Corporation (CGC) Stock Falls Amid Market Uptick: What Investors Need to Know

by Zacks Equity Research

Canopy Growth Corporation (CGC) closed the most recent trading day at $1.44, moving -1.37% from the previous trading session.

Zacks Equity Research

VAREX IMAGING (VREX) Q2 Earnings and Revenues Beat Estimates

by Zacks Equity Research

VAREX IMAGING (VREX) delivered earnings and revenue surprises of 85.71% and 2.93%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Canopy Growth Corporation (CGC) Is a Trending Stock: Facts to Know Before Betting on It

by Zacks Equity Research

Canopy Growth (CGC) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Zacks Equity Research

Perrigo (PRGO) Q1 Earnings Beat Estimates

by Zacks Equity Research

Perrigo (PRGO) delivered earnings and revenue surprises of 7.14% and 3.59%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Why the Market Dipped But Canopy Growth Corporation (CGC) Gained Today

by Zacks Equity Research

In the latest trading session, Canopy Growth Corporation (CGC) closed at $1.28, marking a +0.79% move from the previous day.

Zacks Equity Research

Investors Heavily Search Canopy Growth Corporation (CGC): Here is What You Need to Know

by Zacks Equity Research

Canopy Growth (CGC) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Zacks Equity Research

Here is What to Know Beyond Why Canopy Growth Corporation (CGC) is a Trending Stock

by Zacks Equity Research

Canopy Growth (CGC) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Zacks Equity Research

What Makes Canopy Growth (CGC) a New Buy Stock

by Zacks Equity Research

Canopy Growth (CGC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Zacks Equity Research

Is Trending Stock Canopy Growth Corporation (CGC) a Buy Now?

by Zacks Equity Research

Recently, Zacks.com users have been paying close attention to Canopy Growth (CGC). This makes it worthwhile to examine what the stock has in store.

Urmimala Biswas headshot

Aurora Cannabis Rides the Global Legalization Wave: Should You Invest?

by Urmimala Biswas

ACB capitalizes on the rapidly evolving medical cannabis landscape, leveraging its EU GMP-certified manufacturing facilities, advanced genetics and deep regulatory knowledge.

Zacks Equity Research

Canopy Growth Corporation (CGC) is Attracting Investor Attention: Here is What You Should Know

by Zacks Equity Research

Zacks.com users have recently been watching Canopy Growth (CGC) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Zacks Equity Research

Canopy Growth Corporation (CGC) Is a Trending Stock: Facts to Know Before Betting on It

by Zacks Equity Research

Canopy Growth (CGC) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.